Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Sales | 2 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1 | N/A | N/A | N/A | N/A |
| Gross Profit | 1 | N/A | N/A | N/A | N/A |
| Operating Expenses | 228 | 232 | 248 | 223 | 328 |
| Operating Income | -227 | -232 | -248 | -223 | -328 |
| Interest Expense | 7 | 4 | 4 | 2 | 1 |
| Other Income | 7 | -20 | 0 | -2 | -9 |
| Pre-tax Income | -227 | -256 | -252 | -228 | -338 |
| Net Income Continuous | -227 | -256 | -252 | -228 | -338 |
| Net Income | $-227 | $-256 | $-252 | $-228 | $-338 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-82 | $-112 | $-107 | $-84 | $-196 |